Invasive Mold Disease to High ICU and Ventilation Rates
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
Olorofim may provide a treatment option for patients with disseminated Valley Fever who have failed standard therapies.
The BA.3.2 variant of COVID-19, nicknamed Cicada, features significant genetic changes that may impact vaccine effectiveness for patients with chronic lung disease.
Research suggests only 10 viral particles of the H5N1 bird flu are enough to cause a productive infection in dairy cows.
Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.
A fatty acid in breast milk programs immune cells to fight infections and may reduce the risk of chronic lung disease in premature infants.